Diffuse Cutaneous Systemic Sclerosis
Also known as: Systemic Sclerosis - Diffuse Cutaneous / Diffuse systemic sclerosis / Progressive systemic sclerosis (disorder) / Scleroderma, Diffuse / Systemic sclerosis, diffuse (disorder) / Diffuse scleroderma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00531 | Cyclophosphamide | 1 | Not Yet Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Not Yet Recruiting | 1 |
| DB00688 | Mycophenolate mofetil | 1 | Completed | 1 |
| DB06343 | Teprotumumab | 1 | Terminated | 1 |
| DB08870 | Brentuximab vedotin | 1 / 2 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB18595 | FCR001 | 1 / 2 | Withdrawn | 1 |
| DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
| DB01281 | Abatacept | 2 | Completed | 1 |
| DB00062 | Albumin human | 2 | Withdrawn | 1 |
| DB16703 | Belumosudil | 2 | Terminated | 2 |
| DB08870 | Brentuximab vedotin | 2 | Completed | 1 |
| DB08870 | Brentuximab vedotin | 2 | Recruiting | 1 |
| DB18007 | Dersimelagon | 2 | Completed | 1 |
| DB18124 | Fipaxalparant | 2 | Enrolling by Invitation | 1 |
| DB18124 | Fipaxalparant | 2 | Recruiting | 1 |
| DB00028 | Human immunoglobulin G | 2 | Completed | 1 |
| DB00028 | Human immunoglobulin G | 2 | Withdrawn | 1 |
| DB16666 | Ianalumab | 2 | Recruiting | 1 |
| DB09570 | Ixazomib | 2 | Terminated | 1 |
| DB14801 | Lanifibranor | 2 | Completed | 1 |
| DB12193 | Lenabasum | 2 | Terminated | 1 |
| DB00553 | Methoxsalen | 2 | Not Yet Recruiting | 1 |
| DB00688 | Mycophenolate mofetil | 2 | Not Yet Recruiting | 1 |
| DB18312 | Telitacicept | 2 | Not Yet Recruiting | 1 |
| DB18719 | Tulisokibart | 2 | Recruiting | 1 |
| DB12193 | Lenabasum | 3 | Terminated | 1 |